ReviewFrontiers in oncology2022

Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives.

Lucia Musacchio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.